Louis Herlands

Biography

As Executive Director of Sidra Ventures, Herlands leads commercialization initiatives and entrepreneurship to support Sidra's mission to become a world-class academic health center, focusing on women's and children's health. Louis Herlands innovates at the crossroads of academia, entrepreneurship, finance, and industry. Herlands brings a broad set of experience and expertise in technology commercialization, licensing, start-ups, and translational research. Herlands leverages his scientific expertise to form, finance, and lead successful biotechnology companies that are developing important new medicines in diverse therapeutic areas including diabetes, obesity, pain due to nerve damage, and cancer. The peak value of the publically traded companies he has co-founded, financed and led is in excess of $8 billion. These companies are based on patented new discoveries that have the ability to transform medicine, and help millions of patients worldwide. Herlands graduated from Yale University and received his PhD from The Rockefeller University.

Research Interest

Biotechnology